The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
- Conditions
- HIV InfectionsPeripheral Nervous System Disease
- Interventions
- Drug: Amitriptyline hydrochlorideDrug: Amitriptyline hydrochloride placeboProcedure: Point acupuncture
- Registration Number
- NCT00000817
- Brief Summary
To evaluate the separate and combined efficacy of a standardized acupuncture regimen and amitriptyline on the relief of pain due to peripheral neuropathy and on the quality of life of HIV-infected patients.
Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.
- Detailed Description
Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.
Patients are randomized to receive either standardized point acupuncture or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks. Acupuncture points are located on the lower leg. Patients are evaluated at weeks 6 and 14 and are asked to keep a daily pain diary.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 260
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Amitriptyline hydrochloride Participants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks. 1 Amitriptyline hydrochloride placebo Participants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks. 1 Point acupuncture Participants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks.
- Primary Outcome Measures
Name Time Method Change in quality life Throughout study Change in intensity of pain as measured by the daily pain diary and the global pain relief rating At Weeks 6 and 14 Change in neurological status Throughout study Permanent discontinuation of study treatment due to treatment failure Throughout study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (11)
Harlem AIDS Treatment Group / Harlem Hosp Ctr
🇺🇸New York, New York, United States
Partners Research
🇺🇸Albuquerque, New Mexico, United States
Clinical Directors Network of Region II
🇺🇸New York, New York, United States
Comprehensive AIDS Alliance of Detroit
🇺🇸Detroit, Michigan, United States
Denver CPCRA / Denver Public Hlth
🇺🇸Denver, Colorado, United States
Portland Veterans Adm Med Ctr / Rsch & Education Grp
🇺🇸Portland, Oregon, United States
Veterans Administration Med Ctr / Regional AIDS Program
🇺🇸Washington, District of Columbia, United States
Community Consortium of San Francisco
🇺🇸San Francisco, California, United States
North Jersey Community Research Initiative
🇺🇸Newark, New Jersey, United States
Philadelphia FIGHT
🇺🇸Philadelphia, Pennsylvania, United States
Baltimore Trials
🇺🇸Baltimore, Maryland, United States